Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Perrigo Company plc
  6. News
  7. Summary
    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Nyse  -  04:00 2022-06-24 pm EDT
41.21 USD   +2.23%
06/16Baby formula crunch in U.S. forces scramble to boost supplies
RE
06/15TRANSCRIPT : Perrigo Company plc Presents at Oppenheimer 22nd Annual Consumer and E-Commerce Conference, Jun-15-2022 09:45 AM
CI
06/06Baby formula crunch in U.S. forces scramble to boost supplies
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Former Fresh Del Monte Executive Joins Perrigo as CFO

05/11/2022 | 06:50am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
FRESH DEL MONTE PRODUCE INC. 5.58% 27.45 Delayed Quote.-5.80%
PERRIGO COMPANY PLC 2.23% 41.21 Delayed Quote.3.62%
WOLVERINE WORLD WIDE, INC. 7.12% 21.05 Delayed Quote.-33.84%
All news about PERRIGO COMPANY PLC
06/16Baby formula crunch in U.S. forces scramble to boost supplies
RE
06/15TRANSCRIPT : Perrigo Company plc Presents at Oppenheimer 22nd Annual Consumer and E-Commer..
CI
06/06Baby formula crunch in U.S. forces scramble to boost supplies
RE
06/02Perrigo Company plc Promotes Alison Ives to Executive Vice President and Chief Scientif..
CI
06/02PERRIGO COMPANY PLC : Ex-dividend day for
FA
06/01Perrigo promotes alison ives to role of chief scientific officer
PR
06/01U.S. needs more baby formula makers, Biden tells manufacturers
RE
05/26Perrigo Secures FDA's Final Approval for Omeprazole Heartburn Treatment
MT
05/26Perrigo Company plc Announces U.S. FDA Approval for Omeprazole Magnesium Delayed-Releas..
CI
05/25TIMELINE : Baby formula crunch in U.S. forces scramble to boost supplies
RE
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Financials (USD)
Sales 2022 4 512 M - -
Net income 2022 - - -
Net Debt 2022 3 704 M - -
P/E ratio 2022 -
Yield 2022 2,68%
Capitalization 5 424 M 5 424 M -
EV / Sales 2022 2,02x
EV / Sales 2023 1,83x
Nbr of Employees 9 900
Free-Float 99,4%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 40,31 $
Average target price 50,00 $
Spread / Average Target 24,0%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Eduardo Guarita Bezerra Chief Financial Officer & Executive Vice President
Orlando D. Ashford Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC3.62%5 339
JOHNSON & JOHNSON2.73%462 443
ELI LILLY AND COMPANY11.03%276 070
PFIZER, INC.-16.90%275 327
ABBVIE INC.10.38%260 755
ROCHE HOLDING AG-19.20%259 627